PTPRT and non-small cell lung carcinoma: Via the Kaplan–Meier survival analysis, we demonstrated that PTPRT‐mutated NSCLC patients exhibited a preferable ICI survival outcome than those wild‐type patients (median survival time: 24.0 vs. 6.3 months, Log‐rank test p = 0.024; Figure 5A).